Piramal Pharma Limited's latest marketcap:
3.22 B
As of 06/06/2025, Piramal Pharma Limited's market capitalization has reached $3.22 B. According to our data, Piramal Pharma Limited is the 4436th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.22 B |
| Revenue (ttm) | 1.07 B |
| Net Income (ttm) | 10.62 M |
| Shares Out | 1.33 B |
| EPS (ttm) | 0.01 |
| Forward PE | 145.40 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/09/2025 |
Market Cap Chart
Data Updated: 06/06/2025
Piramal Pharma Limited's yearly market capitalization.
Piramal Pharma Limited has seen its market value grow from ₹136.81 B to ₹276.59 B since 2022, representing a total increase of 102.16% and an annual compound growth rate (CAGR) of 33.50%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₹276.59 B | -21.64% |
| 12/31/2024 | ₹352.98 B | 92.16% |
| 12/29/2023 | ₹183.69 B | 34.26% |
| 12/30/2022 | ₹136.81 B |
Company Profile
About Piramal Pharma Limited
Piramal Pharma Limited is a global pharmaceutical company headquartered in Mumbai, India. Established in 2020, the company operates across North America, Europe, Japan, India, and other international markets.
Business Segments
- Contract Development & Manufacturing (CDMO): Provides end-to-end drug lifecycle services, including discovery, development, and commercial manufacturing of drug substances and products.
- Complex Hospital Generics: Specializes in inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain/anesthesia drugs, and other specialty generics.
- India Consumer Healthcare: Offers a diverse portfolio including analgesics, skincare, vitamin/mineral supplements, kids' wellness, digestives, women’s health, and hygiene products.
Leveraging its global development facilities and distribution network, Piramal Pharma delivers innovative pharmaceutical solutions worldwide.
Frequently Asked Questions
-
What is Piramal Pharma Limited's (NSE-PPLPHARMA) current market cap?As of 06/06/2025, Piramal Pharma Limited (including the parent company, if applicable) has an estimated market capitalization of $3.22 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Piramal Pharma Limited (NSE-PPLPHARMA) rank globally by market cap?Piramal Pharma Limited global market capitalization ranking is approximately 4436 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.